Could a common mushroom help fight prostate cancer?

NCT ID NCT04519879

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 31 times

Summary

This phase 2 trial tests whether white button mushroom extract can lower PSA levels in men with prostate cancer that has returned after treatment or is low-risk and not yet treated. About 133 men will take the supplement or be observed. The goal is to see if the mushroom affects PSA, immune function, and hormone levels tied to cancer growth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

  • City of Hope Rancho Cucamonga

    Rancho Cucamonga, California, 91730, United States

  • City of Hope South Pasadena

    South Pasadena, California, 91030, United States

  • City of Hope West Covina

    West Covina, California, 91790, United States

  • City of Hope at Glendora

    Glendora, California, 91741, United States

  • City of Hope at Irvine Lennar

    Irvine, California, 92618, United States

  • John Wayne Cancer Institute

    Santa Monica, California, 90404, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

White button mushroom extract

What this could lead to

If it works, this could offer a natural supplement to help manage prostate cancer by lowering PSA levels and possibly slowing progression.

What could go wrong

This is a small, early-phase trial that is currently suspended. The supplement may not lower PSA or affect cancer growth, and side effects are not yet well understood.

Conditions

The condition(s) this trial relates to.

prostate adenocarcinoma prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.